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Objective: Fc-gamma receptors (FcgRs) have been shown to play a crucial role in cartilage degradation
during experimental arthritis. Although most of their effect on cartilage degradation has been attributed
to their potential to promote inﬂammation in the presence of immunoglobulins, activating FcgRs pro-
mote cartilage degeneration in antigen-induced arthritis (AIA) independently of the level of inﬂamma-
tion. This prompted us to investigate, whether FcgRs may also play a role in osteoarthritis (OA)-related
cartilage degradation.
Methods: FcgR expression was measured by RT-PCR and FACS in murine cartilage tissue and chon-
drocytes. Experimental OA was induced by destabilisation of the medial meniscus (DMM) in WT mice
and animals lacking either activating (Fc receptor g-chain-deﬁcient) or inhibitory (FcgRIIB-deﬁcient)
FcgRs. Cartilage damage was investigated histologically 8 weeks post-surgery by assessing proteoglycan
loss and structural damage according to OARSI recommendations. Osteophyte size was measured to
investigate alterations in bone turnover.
Results: Expression analyses revealed signiﬁcant levels for all four types of murine FcgRs in mouse
chondrocytes and cartilage tissue from newborn and 8-week-old mice. Surprisingly, yet, ablation of
either activating or inhibitory FcgRs did not affect cartilage damage or bone turnover during DMM-
induced OA in mice.
Conclusion: While FcgRs appear to have a crucial role in cartilage degradation during inﬂammatory
arthritis our data indicate that FcgRs do not inﬂuence cartilage destruction in experimental OA. This
indicates that a certain threshold of inﬂammation is a prerequisite for FcgR-induced cartilage destruction
in arthritis.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Articular cartilage degradation is one of the primary hallmarks
of both inﬂammatory and degenerative joint diseases and promi-
nently contributes to their disease burden. In contrast to bone andM. Stock, Department of In-
g, 91054 Erlangen, Germany.
de (M. Stock), alﬁya.distler@





ternational. Published by Elsevier Lother mesenchymal tissues, cartilage does not sufﬁciently regen-
erate after injury, even if the trigger for cartilage loss can be
controlled by clinical intervention. Therefore, the investigation of
the pathological molecular events that disturb the balance of
cartilage turnover is a prerequisite for future therapies that aim to
restore cartilage homeostasis.
In inﬂammatory arthritis, resident ﬁbroblasts and macrophages
secrete large amounts of catabolic enzymes, particularly aggreca-
nases of the ADAMTS (a disintegrin and metalloproteinase with
thrombospondin motifs) family and collagenases of the matrix
metalloproteinase (MMP) family, which degrade the cartilage ma-
trix, ultimately destroying the articular cartilage1. In osteoarthritis
(OA), cartilage breakdown results from a dysbalance of cartilage
matrix synthesis and degradation. Thus, corrupt TGFb signallingtd. All rights reserved.
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tivity of ADAMTS and MMPs in chondrocytes2. Together with a
decrease in the production of cartilage matrix proteins such as
aggrecan and collagen type II, a dysbalance in cartilage turnover
occurs which leads to cartilage loss in OA2,3. Although inﬂamma-
tory arthritis and OA are very different pathologies, the terminal
pathway leading to cartilage destruction appears to involve com-
mon mechanisms with ADAMTS- and MMP-mediated degradation
of the cartilage matrix.
Previous studies have shown that the absence of activating Fcg
receptors (FcgRI, FcgRIII, and FcgRIV) abrogated cartilage destruc-
tion during experimental arthritis, indicating a critical role of FcgR
signalling in the process of cartilage destruction in arthritis4,5. This
has been mostly attributed to the role of FcgRs in immunoglobulin-
dependent activation of macrophages and neutrophils during
inﬂammation6,7. However, in antigen-induced arthritis (AIA), loss of
activating Fcg receptors has been shown to uncouple inﬂammation
and cartilage destruction4. Together with the ﬁnding that FcgRIIB
and III are expressed in chondrocytes this may point to a direct role
of FcgR signalling in chondrocyte activity and cartilage
degradation8.
In this study, we demonstrate that all four murine types of FcgRs
are present in mouse chondrocytes. Therefore, we hypothesised
that FcgR signalling may also play a role in the progression of OA. In
order to test this hypothesis we surgically induced experimental OA
inwild-type animals, in mice devoid of the Fc receptor g-chain (and
therefore deﬁcient in activating FcgRI, FcgRIII and FcgRIV), and in
FcgRIIB-deﬁcient mice and investigated OA-dependent cartilage
damage. Surprisingly, however, the lack of FcgR did not alter the
severity of cartilage destruction in experimental OA.Methods
Cells
Primary murine chondrocytes were isolated from epiphyses or
rib cages of newborn mice (aged 3e5 days) by consecutive enzy-
matic digestion with trypsin and collagenase P as previously re-
ported9. To minimise phenotypical changes chondrocytes were
cultured in monolayers for no longer than 7 days with a maximum
of one passage. Macrophages were isolated from bone marrow by
ﬂushing the femurs and tibias of 8e10 week-old C57BL/6 WT mice.
The next day, non-adherent cells were collected and cultured in a-
MEM medium containing 10% FCS, 1% Penicillin/Streptomycin and
30 ng/ml of M-CSF (R&D) for 7 days.Gene expression analysis
For gene expression analyses RNAwas extracted from epiphyseal
cartilage dissected from newborn mice or from articular cartilage
dissected from the femoral heads of 8-week-old mice or from
cultured cells using the RNeasy (Fibrous Tissue for tissue) Kit (Qia-
gen) according to the manufacturer's instructions. RT-PCR for the
detection of collagen2a1 (Col2a1) and cyclophilin A was carried out
as previously reported using the Superscript II reverse transcriptase
system (Invitrogen) and the TaqPCR Core Kit (Qiagen)10. Additional
gene-speciﬁc primers: FcgRI: 50-TTAAGCGCAGCCCTGAGT-30 (for-
ward), 50-TCCCACTGACAGATAAAACAGG-30 (reverse); FcgRIIB: 50-
AAAGCAGGTTCCAGACAATCC-30 (forward), 50-GATGCTTGAGAAGTG
AGTAGGTGAT-30 (reverse); FcgRIII: 50-CAAGCCTGTCACCATCACTG-30
(forward), 50-GAGGCACATCACTAGGGAGAA-30 (reverse); FcgRIV: 50-
GGGCTCATTGGACACAACA-30 (forward), ATGGATGGAGACCCTGGAT
(reverse). CD45: 50-CCTCTGGAGGCTGAATACCA-30 (forward), 50-
TGCTCATCTCCAGTTCATGC-30 (reverse).FACS analysis
Rib chondrocytes from newborn WT or FcgRIIB-/FcRg-chain-
double-deﬁcient mice were trypsinised and passed through a
cell strainer. After blocking with Fc block (2.4G2 or 9E9
respectively, both self-produced) cells were stained with an
antibody mixture containing DAPI, APC-Cy7-labelled CD45
(clone 30-F11; BioLegend), Pe-Cy7-labelled CD31 (clone 390;
BioLegend) and either APC-labelled FcgRI (CD64; clone X54-5/
7.1, BD Biosciences), FcgRIIB (clone Ly17.2, self-produced),
FcgRIII (CD16; clone 275003, R&D Systems) or FcgRIV (clone
9E9, self-produced). Data acquisition and analysis was per-
formed with FACS Diva software (BD Biosciences). Chondrocytes
were gated as alive SSChigh, CD45- and CD31- cells after
exclusion of doublets.Mice and induction and scoring of experimental OA
C57BL/6 mice were obtained from Elevage Janvier. FcgRIIB-
deﬁcient (generated on C57BL/6 background), FcRg-chain-deﬁcient
and FcgRIIB-/FcRg-chain-double-deﬁcient mice (both backcrossed
onto C57BL/6 background for at least 13 generations) were pro-
vided by Jeffrey Ravetch (The Rockefeller University, New York).
Phenotypical abnormalities of the musculoskeletal system have not
been described for untreated mutant mice used in this study,
except for some minor reduction of osteoclast counts in FcRg-
chain-deﬁcient mice, which did not affect bone homeostasis11. We
could not observe any signiﬁcant abnormalities in growth, fertility,
development or morphology of the musculoskeletal system of the
mutant mice. Mutant mice were indistinguishable in size and
weight from WT C57/B6 mice. Experimental OA was induced by
destabilisation of the medial meniscus (DMM) through surgical
transection of the medial meniscotibial ligament in male mice at
the age of 8 weeks. Sham surgery was performed in the same way,
including anaesthesia and opening of the knee capsule, but without
transecting the ligament. DMM and sham operations were carried
out in separate groups with both legs undergoing surgery. Eight
weeks post-surgery mice were sacriﬁced and frontal parafﬁn sec-
tions (4 mm) of the knees were prepared and stained with Safranin-
O. Proteoglycan-loss was quantiﬁed by determining the proportion
of Safranin-O staining-negative articular cartilage using ImageJ
software. OA scoring was performed in a blinded manner according
to OARSI recommendations, scoring all four quadrants (medial and
lateral femoral condyles, medial and lateral tibial plateaus) in
multiple step sections through the joint12. Maximal scores from all
four quadrants were cumulated. Osteophyte size at the medial tibia
was measured on Safranin-O stained sections using ImageJ soft-
ware. n ¼ 6 per group. All animals were maintained under speciﬁc
pathogen-free conditions. All experiments were performed with
the approval of the local ethics authorities (Tierschutzbeauftragter
of the University of Erlangen-Nuremberg and the Government of
Mittelfranken, Ansbach, Germany) and according to the rules and
regulations of the animal facilities in Germany and the United
States.Statistical analysis
Data are presented as the mean ± 95% CI. Statistical signiﬁcance
was evaluated by one-way analysis of variance (ANOVA) and
Tukey's multiple comparison test after conﬁrming normal distri-
bution using the KolmogoroveSmirnov test. Additionally, signiﬁ-
cance was evaluated using the ManneWhitney test. Statistical
analysis was performed using Graph-Pad Prism software.
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Fcg receptors are expressed in murine chondrocytes
In order to investigate, which types of FcgRs are expressed in
cartilage, gene expression of all four murine types of FcgR was
analysed by RT-PCR and compared with their expression in bone
marrow macrophages. Substantial collagen2a1 expression
conﬁrmed the chondrocyte phenotype, and lack of CD45 expres-
sion excluded a contamination of cartilage tissue and primary
chondrocyte cultures with haematopoietic cells. As expected these
analyses conﬁrmed the expression of FcgR types IIB and III in
epiphyseal cartilage, and in chondrocytes from epiphyses and ribs
from newborn mice. Moreover, cartilage and chondrocytes also
exhibited signiﬁcant expression levels of FcgR types I and IV (except
rib chondrocytes) [Fig. 1(A)]. Furthermore, FcgR expression
remained stable in articular cartilage from adult mice at the age of 8
weeks as compared to epiphyseal cartilage from newborn mice
[Fig. 1(A)]. Finally, speciﬁc cell surface expression could be
demonstrated for FcgRI in 4 of 4 experiments, and for FcgRIIB and
FcgRIII in 3 of 4 experiments using FACS analysis. FcgRIV could only
be detected in 2 of 4 experiments. A typical experiment for FcgRI-III
protein expression is shown in Fig. 1(B).
These results indicate signiﬁcant expression of Fcg receptors in
cartilage and may point to a direct role for FcgR signalling in
chondrocyte biology.
Loss of activating or inhibitory Fcg receptors does not alter
development of experimental OA
Since FcgR signalling is involved in cartilage degradation during
inﬂammatory arthritis4 we assessed the effect of FcgR ablation in
an experimental OA model. Therefore, we induced OA in 8-week-
old FcR-g-chain-deﬁcient (devoid of all activating FcgRs), FcgRIIB-
deﬁcient, and wild-type C57BL/6 mice. Eight weeks post-surgery
OA-related cartilage damage was investigated histologically by
quantifying proteoglycan loss as Safranin-O-staining negative
cartilage [Fig. 2(A) and (B)] and structural cartilage damage using
the OARSI score for mouse OA [Fig. 2(A) and (C)]. While sham-
operated control mice of all groups investigated did not exhibit
signiﬁcant or different levels of proteoglycan loss (P ¼ 0.65) orFig. 1. FcgRs are expressed in murine chondrocytes. A: Total RNA was extracted from muri
macrophages. RT-PCR analyses were performed to detect mRNA levels of FcgR types I, IIB, I
ECart: epiphyseal cartilage; EC: epiphyseal chondrocytes; RC rib chondrocytes; ACart: artic
FcgRIIB-/FcRg-chain-double-deﬁcient (KO) mice were analysed for FcgR cell surface expres
compared with unstained samples of a typical experiment. All experiments shown were pecartilage destruction (P ¼ 0.74), all mice that had undergone DMM
surgery developed a signiﬁcant (all P < 0.001, when compared to
sham controls) degree of OA-mediated proteoglycan loss and
structural cartilage damage. Surprisingly, however, there was no
signiﬁcant difference in proteoglycan loss (P ¼ 0.63) or structural
changes (P ¼ 0.98) observed in WT mice and mice deﬁcient in
either activating or inhibitory FcgRs. Similar to cartilage destruc-
tion, osteophyte formation was barely detectable and not signiﬁ-
cantly different in sham-operated mice of either genotype
(P ¼ 0.16). In contrast, signiﬁcant development of osteophytes (all
P < 0.001, when compared to sham controls) was observed in either
WT or FcgR mutant strains after DMM surgery. Osteophyte size
after DMM surgery, however, did not signiﬁcantly differ between
WT, FcgRIIB- and FcR g-chain-deﬁcient mice (P ¼ 0.90) [Fig. 2(D)].
One-way ANOVA to test for statistical signiﬁcance shown here was
conﬁrmed using ManneWhitney tests (Suppl. Table 1). These data
indicate that FcgRs are not involved in cartilage degeneration or
bone remodelling during experimental OA.
Discussion
This study aimed to investigate a potential direct effect of FcgR
signalling on cartilage destruction during experimental OA.
Therefore, we studied FcgR expression in murine chondrocytes and
found all four types of FcgR being signiﬁcantly expressed. Sur-
prisingly, however, histological evaluation of cartilage damage in
mice lacking either activating or inhibitory FcgRs revealed no dif-
ference in the OA-associated cartilage changes compared to Fcg-
receptor expressing wild-type controls.
Recent studies have put emphasis on the prominent role of FcgR
signalling in the process of cartilage degradation during inﬂam-
matory arthritis. Immune complexes containing autoantibodies,
which trigger FcgR signalling, are abundantly present in articular
cartilage during arthritis. OA cartilage samples also show elevated
levels of immune complexes13. FcgR signalling has been shown to
be particular important for macrophage activation. Macrophage
activation in turn has been demonstrated to be a key factor in
cartilage degeneration during inﬂammatory arthritis4,14. In
contrast, in the AIA model of inﬂammatory arthritis, Lent and col-
leagues found that activating FcgRs are necessary for arthritis-
triggered cartilage destruction, independently of the level ofne chondrocytes, newborn epiphyseal cartilage, adult (8 weeks) articular cartilage and
II, and IV, collagen2a1 (Col2a1) and CD45. Cyclophilin A was used as a reference gene.
ular cartilage; MF (bm): bone marrow macrophages. B: Rib chondrocytes from WT or
sion using ﬂow cytometry. Shown is the delta median ﬂuorescence intensity (D MFI)
rformed at least three times with comparable results.
Fig. 2. Deﬁciency in FcgRs does not alter cartilage damage in DMM-induced OA. DMM or sham surgery was performed in WT, FcgRIIB-deﬁcient (RIIB), or FcR g-chain-deﬁcient (g)
mice. Eight weeks post-surgery, cartilage damage and osteophyte development was investigated histologically. A: Safranin-O staining of frontal knee sections showing the medial
part of the stiﬂe joint. B: Quantiﬁcation of proteoglycan (PG) loss, determined as the fraction of Safranin-O staining negative articular cartilage (Saf-O neg. cart.). C: Scoring of OA-
induced cartilage damage according to OARSI recommendations. Maximal scorings of all four quadrants of the joint were cumulated per mouse. D: Osteophyte development was
determined by measuring the size of osteophytes at the medial tibiae. Mean values ± 95% CI are shown. n ¼ 6.
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synovial macrophages may trigger these cells to secrete catabolic
mediators, such as oxygen radicals, TNFa and MMPs, which in turn
mediate cartilage destruction through chondrocyte death and
matrix degeneration4.
In this study, we provide evidence for signiﬁcant expression of
all four types of murine FcgRs in newborn and adult mouse carti-
lage. At least for FcgR types IeIII we could also provide evidence for
cell surface expression on chondrocytes. These ﬁndings encouraged
us to investigate, whether FcgR signalling in chondrocytes may
serve as an alternative or additional pathway, how FcgRs might
contribute to cartilage destruction during joint diseases. In order to
test this hypothesis we investigated cartilage degeneration in the
DMM mouse model for OA, which is known to develop only mar-
ginal levels of inﬂammation and macrophage invasion15. Surpris-
ingly, however, we found that cartilage degradation, as well as
osteophyte formation, was independent of the presence of either
activating or inhibitory FcgRs in the DMM model.
These data indicate that FcgRs are not involved in the process of
cartilage destruction or bone remodelling during DMM-induced OA
in mice. Hence, FcgR-dependent cartilage degradation may rely on
an inﬂammatory background, present in murine and human in-
ﬂammatory arthritis. The role of FcgR expression and cell surface
expression in chondrocytes remains to be elucidated.
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